ACE2 and diabetes mellitus: The strength of stimulating the catalytic activity of tubular ACE2 is the ability to both produce tissue Ang 1-7 and degrade excess Ang II, thereby reducing tubular fibrosis and inflammation in the setting of diabetes (Figure 1).